EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens

Xiaoping Zhang, Guoli Mo, Fengjia Zhu, Kaiwen Zhang, Lijie Tian, Yueran Lv, Jing Chen

Precision Medication · 2026-03 · 3 (1) · 100082

DOI: 10.1016/j.prmedi.2026.100082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Medication, 2026-03. Verfasst von Xiaoping Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, X., Mo, G., Zhu, F., Zhang, K., Tian, L., Lv, Y., & Chen, J. (2026). Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens. Precision Medication, 3(1), 100082. https://doi.org/10.1016/j.prmedi.2026.100082

Vancouver

Zhang X, Mo G, Zhu F, Zhang K, Tian L, Lv Y, et al. Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens. Precision Medication. 2026;3(1):100082. doi:10.1016/j.prmedi.2026.100082

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoping and Mo, Guoli and Zhu, Fengjia and Zhang, Kaiwen and Tian, Lijie and Lv, Yueran and Chen, Jing},
  title = {Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens},
  journal = {Precision Medication},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {100082},
  doi = {10.1016/j.prmedi.2026.100082}
}
Kostenlos starten →